RCS - Releaf Dispensary Ld - Releaf: First UK Medical Cannabis Legal Helpline

TrustpilotAnnouncement

Yesterday 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260115:nRSO0922Pa&default-theme=true

RNS Number : 0922P  Releaf Dispensary Ltd  15 January 2026

First of its kind in the UK as medical cannabis patients get on-demand legal support with their prescription
The UK's leading medical cannabis clinic launches the service offering prescribed patients on-demand legal guidance following updated police guidance.

 

January 15, 2026. Releaf (https://releaf.co.uk/) , the UK's fastest-growing
medical cannabis clinic, has today announced the launch of Releaf Protect, a
first-of-its-kind for UK cannabis patients legal guidance service designed to
strengthen patient confidence and protection.

Available to eligible members as part of Releaf+, the most comprehensive
subscription plan for cannabis patients, Releaf Protect provides access to a
dedicated legal helpline offering practical, situation-specific guidance for
issues connected to lawful medical cannabis treatment in the UK.

The launch follows the recent publication of an updated police report last
week, which provided new guidance on how officers should approach interactions
with legally prescribed medical cannabis patients. While this represents an
important step forward for patient clarity, many patients still face
uncertainty in high-pressure, real-world situations.

Tim Kirby, CEO of Releaf, said, "Medical cannabis has been legal in the UK for
several years, yet patients are still too often left carrying the burden of
explaining the law in moments that can feel intimidating or stressful. As the
UK's leading medical cannabis healthcare provider, we believe our
responsibility doesn't end with prescribing; it extends to ensuring patients
feel supported, protected and confident in everyday life. Releaf Protect is a
meaningful step towards closing that gap, offering practical, responsible
support at the moments it genuinely matters."

The service is intended for specific, active situations, such as workplace
disputes and interactions with police or other authorities. It forms part of
Releaf's wider commitment to leading innovation in the UK cannabis industry,
alongside the Releaf Medical Cannabis Card
(https://releaf.co.uk/medical-cannabis-card) , providing patients with clear,
verifiable evidence of their prescription.

Kirby added, "Releaf continues to lead the industry in patient care and
confidence. Our Medical Cannabis Card is uniquely supported by a secure
two-factor verification process, enabling third parties to independently
confirm a patient's lawful prescription if it is ever challenged. The card and
new legal guidance service, combined with our one-of-a-kind technology
platform, reflects our ongoing commitment to innovation,  building real-world
solutions that make medical cannabis safer, clearer and more accessible for
patients across the UK."

The legal guidance is provided by Irwin Mitchell
(https://www.irwinmitchell.com/) , a leading UK law firm with extensive
experience advising on regulatory, employment, and public law matters. Releaf
does not receive the content of legal advice and does not influence the
guidance given, ensuring patients receive independent, situation-specific
support when it is needed most.

Together, these initiatives are designed to give prescribed medical cannabis
patients greater confidence in everyday situations. By improving clarity,
reducing misunderstandings and helping prevent unnecessary escalation, Releaf
aims to promote better awareness and understanding of lawful medical cannabis
prescriptions across the UK.

 

 

 

 END 
 
About Releaf

Launched in 2024, Releaf is the UK's fastest-growing and most-trusted* medical
cannabis clinic, serving patients through its advanced healthtech platform.
With a prescriber base of over 50 specialists, we deliver evidence-based
cannabinoid care directly to patients' homes through tailored treatment plans.
Integrated with NHS systems, Releaf (https://releaf.com) has transformed
access to medicinal cannabis treatment in the UK and is now expanding
internationally. *According to Trustpilot
(https://uk.trustpilot.com/review/releaf.co.uk) and CAC
(https://cannabisaccessclinics.co.uk/) .

 

For more information contact press@releaf.co.uk (mailto:press@releaf.co.uk) or
visit www.releaf.co.uk (http://www.releaf.co.uk/)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGPUUPGUPQGGA



            Copyright 2019 Regulatory News Service, all rights reserved